1. Safety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccine: a randomised, double-blind, placebo-controlled, phase 1 clinical trial. Issue 4 (April 2020) Authors: Clarke, David K; Xu, Rong; Matassov, Demetrius; Latham, Theresa E; Ota-Setlik, Ayuko; Gerardi, Cheryl S; Luckay, Amara; Witko, Susan E; Hermida, Luz; Higgins, Terry; Tremblay, Marc; Sciotto-Brown, Susan; Chen, Tracy; Egan, Michael A; Rusnak, Janice M; Ward, Lucy A; Eldridge, John H Journal: Lancet infectious diseases Issue: Volume 20:Issue 4(2020) Page Start: 455 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗